Jeffrey Gene Lee serves as Executive at BlackRock Health Sciences Trust, where they oversee executive responsibilities. Since joining the company, Jeffrey Gene Lee has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 31, 2023 involved exercising options for 204.57 shares valued at $0.
Jeffrey Gene Lee currently holds 204.57 shares of BlackRock Health Sciences Trust (BME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Gene Lee has been a net neutral trader of BME stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Gene Lee's most recent insider trade was on Jan 31, 2023, when they sold 204.57 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 204.57 |
| $43.56 |
| Discretionary |
| Jan 31, 2022 | BME | $3.2K | Disposition | 71.45 | $45.10 | Discretionary |
| Jan 31, 2022 | BME | $0 | Option Exercise | 71.45 | $N/A | Discretionary |